The Galactocerebrosidase pipeline drugs market research report outlays comprehensive information on the Galactocerebrosidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Galactocerebrosidase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Central Nervous System which include the indications Globoid Cell Leukodystrophy (Krabbe Disease). It also reviews key players involved in Galactocerebrosidase targeted therapeutics development with respective active and dormant or discontinued products.
The Galactocerebrosidase pipeline targets constitutes close to seven molecules. Out of which, approximately seven molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase II, Preclinical, and Discovery stages are 1, 2, and 4 respectively.
Galactocerebrosidase overview
Galactosylceramidase is an enzyme that in humans is encoded by a gene GALC. This enzyme hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride. Enzyme with very low activity responsible for the lysosomal catabolism of galactosylceramide, a major lipid in myelin, kidney and epithelial cells of small intestine and colon. Mutations in this gene have been associated with Krabbe disease, also known as globoid cell leukodystrophy.
For a complete picture of Galactocerebrosidase’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.